Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarctionKenneth W. Mahaffey, Christopher B. Granger, Paul R. Eisenberg et al.|Journal of the American College of Cardiology|1999Cited by 541
Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trialJordana B. Cohen, Julio A. Chirinos, Thomas C. Hanff et al.|The Lancet Respiratory Medicine|2021Cited by 224
Randomized elimination and prolongation of ACE inhibitors and ARBs in coronavirus 2019 (REPLACE COVID) Trial ProtocolJordana B. Cohen, Julio A. Chirinos, Thomas C. Hanff et al.|Journal of Clinical Hypertension|2020Cited by 19